#JGAF2024

Program

Page 1
Page 2
Page 3
Page 4
Page 6
Page 7

Dec 16 Day 1

7:30-9:00

Reception and registration of participants

9:00-9:20

Plenary

Epidemiology of digestive cancers in Africa, Rwanda context (Dr. Theoneste Maniragaba & RBC Team)

9:20-9:40

Plenary

H. pylori and gastric cancer (causality, role of eradication, challenge in eradication and resistance) (Ruffin Ntounda)

9:40-10:00

Plenary

Pathological appearance of gastrointestinal tumors (Ass. Prof Belson Rugwizangoga / Pathology team)

10:00-10:30

Plenary

Panel discussion

10:30-11:00

Coffee break

11:00-11:20

Plenary

Epidemiology and risk factors of digestive cancers in Africa (Dr. Raïmi Kpossou)

11:20-11:35

Plenary

Question and answer session

11:40-11:50

Plenary

Welcome remarks – President of the Rwandan Society of Endoscopy (RSE) (Dr. Vincent Dusabejambo)

11:50-12:00

Plenary

Speech by the President of SAHGE (Dr. Innocent Ngo)

12:00-12:10

Plenary

Speech: President of the International Scientific Committee (SAHGE)

12:10-12:20

Plenary

Training in gastroenterology and hepatology in Rwanda (Principal of CMHS)

12:20-12:30

Plenary

Video: Endoscopy and oncology roadmap – integrated management (Julien (RCCH), Dr. Dadamesi, Prof. Bensen and Dr. Vincent)

12:30-12:45

Plenary

Speech by Hon. Minister of Health (Honourable Minister Sabin Nsanzimana)

12:45-13:00

Group photo

13:00-14:00

Lunch

14:00-14:20

Plenary

Prevention of mother-to-child transmission of hepatitis B in Africa: what is the reality? (Dr Alice Guingane)

14:20-14:40

Plenary

Management of hepatitis B&C, the path to eradication: The case of Rwanda. (Dr. Makuza and Dr. Serumondo (RBC)) 

14:40-15:00

Plenary

Hepatitis B and C: Epidemiology and treatment in Africa (Ass Prof. Hanna Aberra)

15:00-15:30

Plenary

Discussion

15:30-15:45

Coffee break and posters

15:45-16:05

Plenary

Inflammatory Bowel Disease (IBD): Prof (Frederick Colombel)

16:05-16:25

Plenary

Metabolic Associated Fatty Liver Disease (MAFLD): Challenges and Solutions (AFEF – Professor Paul Calès)

16:25-16:55

Plenary

Discussion